Consolidated Statement Of Cash Flows

WAKAMOTO PHARMACEUTICAL CO.,LTD. - Filing #7537523

Concept 2023-04-01 to
2023-09-30
As at
2023-09-30
As at
2023-03-31
2022-04-01 to
2022-09-30
As at
2022-09-30
As at
2022-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
133,619,000 JPY
248,363,000 JPY
Interest and dividends received
30,079,000 JPY
24,981,000 JPY
Interest paid
-239,000 JPY
-292,000 JPY
Income taxes paid
-54,786,000 JPY
-22,066,000 JPY
Net cash provided by (used in) operating activities
108,673,000 JPY
254,291,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-85,467,000 JPY
-43,470,000 JPY
Net cash provided by (used in) investing activities
78,066,000 JPY
149,649,000 JPY
Purchase of investment securities
-2,183,000 JPY
-2,133,000 JPY
Proceeds from sale of investment securities
229,834,000 JPY
JPY
Cash flows from financing activities
Purchase of treasury shares
-9,000 JPY
-22,000 JPY
Dividends paid
-103,779,000 JPY
-479,000 JPY
Net cash provided by (used in) financing activities
-104,307,000 JPY
-1,031,000 JPY
Net increase (decrease) in cash and cash equivalents
82,432,000 JPY
402,909,000 JPY
Cash and cash equivalents
3,961,757,000 JPY
3,879,325,000 JPY
3,634,798,000 JPY
3,231,889,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.